Kindred Bio to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 6th

[PR Newswire] – SAN FRANCISCO, Feb. 27, 2014 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it will release … more

View todays social media effects on KIN

View the latest stocks trending across Twitter. Click to view dashboard

See who Kindred is hiring next, click here to view